Activation of the type I interferon (IFN) pathway and autoreactive B cells are key immunopathogenic features of systemic lupus erythematosus (SLE), primary Sjögren’s disease (pSjD) and systemic sclerosis (SSc). This evidence concerns the gene IFNA1 and systemic sclerosis.